首页 | 本学科首页   官方微博 | 高级检索  
     

Rb94对人肺腺癌裸鼠移植瘤的抑制作用及SphK表达影响的研究*
引用本文:张萍,刘芳,栾力,马道新,王建波,谭炳煦,程玉峰. Rb94对人肺腺癌裸鼠移植瘤的抑制作用及SphK表达影响的研究*[J]. 中国肿瘤临床, 2010, 37(9): 481-484. DOI: 10.3969/j.issn.1000-8179.2010.09.001
作者姓名:张萍  刘芳  栾力  马道新  王建波  谭炳煦  程玉峰
作者单位:作者单位:山东大学齐鲁医院放疗科(济南市250012);①山东医学高等专科学校
基金项目:山东省科技攻关项目资助 
摘    要:目的:Rb94基因转染裸鼠肺腺癌皮下移植瘤,观察Rb94基因对人肺腺癌裸鼠移植瘤的抑制作用及对鞘氨醇激酶(sphingosine kinase ,SphK)表达的影响。方法:收集一定数量的对数生长期A549 细胞,生理盐水重悬后每只裸鼠右后肢皮下接种5 × 106/0.1mL A549 细胞悬液,待瘤体生长至一定体积后随机分为4 组,分别为对照组、空载体组、脂质体组、转染Rb94基因组;每组裸鼠瘤体内分别注射PBS 、质粒pIRES 、脂质体(lipofectamine)、质粒pIRES-Rb94,观察肿瘤生长情况并检测抑瘤率;裸鼠脱颈处死后,采用Western bolt法检测瘤组织中Rb94基因表达情况,并采用实时RT-PCR 和免疫荧光法(immunofluorescence,IF )观察其对裸鼠肺腺癌皮下移植瘤中SphK表达的影响。结果:对照组及转染组裸鼠在接种部位均有移植瘤生成;与空白对照组、脂质体组、空载体组相比,转染Rb94 基因组的裸鼠移植瘤的生长速度明显减慢,肿瘤的体积较小,重量较轻,有显著性差异(P<0.05),而3 个对照组之间,无显著性差异(P>0.05);空白对照组、空载体组、脂质体组抑瘤率分别为0、11.78% 、7.86% ,而转染Rb94基因组平均抑瘤率高达51.99% ,肿瘤生长明显抑制;SphK1 在mRNA 和蛋白水平表达下调而SphK2 表达上调。结论:Rb94基因成功转染裸鼠肺腺癌皮下移植瘤;Rb94基因抑制裸鼠皮下肿瘤生长;Rb94基因抑制SphK1 的表达,增强SphK2 的表达。 

关 键 词:鞘氨醇激酶   A549 细胞   小鼠   移植瘤
收稿时间:2010-01-29

Inhibitory Action of the Retinoblastoma 94 Gene on Human Lung Adenocarcinoma and Its Effect on the Expression of SphK in a Mouse Xenograft Model
Affiliation:1Department of Radiation Oncology, Qilu Hospital of Shandong University, Ji'nan, 250012, China
Abstract:Objective: To construct an animal model of pIRES-Rb94transfection of the A549 adenocarcinoma cells to investigate the inhibitory action and effect on the expression of SphK in a mouse xenograft model. Methods:Cell suspen-sions at 5 × 10 6/0.1mL were subcutaneously injected into flanks of every nude mouse. Then the inoculated mice were divid-ed into4 groups as follows: with PBS; with lipofectamine; with pIRES empty vector; and with pIRES-Rb 94. The inhibitory rate was observed and the expression of the Rb 94gene was detected by Western blot. Then its effect on SphK expression was determined by RT-PCR and immunofluorescence. Results: The growth of tumor graft was obviously inhibited in the treatment group. The inhibitory ratio of the transplanted tumor was 51.99% in the pIRES-Rb94group, higher than that in the control group ( 0), lipofectamine group (7.86% ) and pIRES group (11.78% ), with significant differences between pIRES-Rb94group and the other three groups (P<0.01). The expression of SphK 1 was down-regulated and the expression of SphK 2 was up-regulated. Conclusion:Mouse xenograft model of lung adenocarcinoma was successfully constructed us-ing eukaryotic expression plasmid containing pIRES-Rb 94gene. Rb94can effectively inhibit the growth of lung adenocarci -noma and the expression of SphK1 but can enhance SphK2 expression. 
Keywords:
本文献已被 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号